BACKGROUND: Human herpesvirus (HHV) infections are common during infancy. Primary infections are frequently asymptomatic and best studied prospectively by using direct viral detection. METHODS: Oropharyngeal swab specimens were collected weekly from Ugandan newborn infants, their mothers, and other children in the household. Blood specimens were collected every 4 months. Samples were tested for herpes simplex virus (HSV) types 1 and 2, Epstein-Barr virus (EBV), cytomegalovirus (CMV), HHV-6A, HHV-6B, and HHV-8, using quantitative polymerase chain reaction. RESULTS: Thirty-two infants, 32 mothers, and 49 other household children were followed for a median of 57 weeks. Seventeen mothers had human immunodeficiency virus type 1 (HIV) infection; no infants acquired HIV-1. The 12-month incidence of postnatal infection was 76% for HHV-6B, 59% for CMV, 47% for EBV, 8% for HSV-1, and 0% for HHV-8. The quantity of oropharyngeal shedding by contacts was associated with HHV-6A or HHV-6B transmission. Maternal HIV-1 infection was associated with EBV transmission, while breastfeeding and younger child contacts were associated with CMV transmission. Except for HSV-1, primary HHV infections were subclinical. CONCLUSIONS: By capturing exposures and acquisition events, we found that the incidence and risk factors of infection vary by HHV type. HSV-1 infection, unlike other HHV infections, caused acute clinical illness in these infants.
BACKGROUND:Humanherpesvirus (HHV) infections are common during infancy. Primary infections are frequently asymptomatic and best studied prospectively by using direct viral detection. METHODS: Oropharyngeal swab specimens were collected weekly from Ugandan newborn infants, their mothers, and other children in the household. Blood specimens were collected every 4 months. Samples were tested for herpes simplex virus (HSV) types 1 and 2, Epstein-Barr virus (EBV), cytomegalovirus (CMV), HHV-6A, HHV-6B, and HHV-8, using quantitative polymerase chain reaction. RESULTS: Thirty-two infants, 32 mothers, and 49 other household children were followed for a median of 57 weeks. Seventeen mothers had humanimmunodeficiency virus type 1 (HIV) infection; no infants acquired HIV-1. The 12-month incidence of postnatal infection was 76% for HHV-6B, 59% for CMV, 47% for EBV, 8% for HSV-1, and 0% for HHV-8. The quantity of oropharyngeal shedding by contacts was associated with HHV-6A or HHV-6B transmission. Maternal HIV-1 infection was associated with EBV transmission, while breastfeeding and younger child contacts were associated with CMV transmission. Except for HSV-1, primary HHV infections were subclinical. CONCLUSIONS: By capturing exposures and acquisition events, we found that the incidence and risk factors of infection vary by HHV type. HSV-1 infection, unlike other HHV infections, caused acute clinical illness in these infants.
Authors: Michael Boeckh; MeeiLi Huang; James Ferrenberg; Terry Stevens-Ayers; Laurence Stensland; W Garrett Nichols; Lawrence Corey Journal: J Clin Microbiol Date: 2004-03 Impact factor: 5.948
Authors: Soren Gantt; Abel Kakuru; Anna Wald; Victoria Walusansa; Lawrence Corey; Corey Casper; Jackson Orem Journal: Pediatr Blood Cancer Date: 2010-05 Impact factor: 3.167
Authors: K Kusuhara; A Takabayashi; K Ueda; Y Hidaka; I Minamishima; H Take; K Fujioka; S Imai; T Osato Journal: Microbiol Immunol Date: 1997 Impact factor: 1.955
Authors: Petter Brodin; Vladimir Jojic; Tianxiang Gao; Sanchita Bhattacharya; Cesar J Lopez Angel; David Furman; Shai Shen-Orr; Cornelia L Dekker; Gary E Swan; Atul J Butte; Holden T Maecker; Mark M Davis Journal: Cell Date: 2015-01-15 Impact factor: 41.582
Authors: Ibrahim I Daud; Carrie B Coleman; Nicholas A Smith; Sidney Ogolla; Kenneth Simbiri; Elizabeth A Bukusi; Zipporah W Ng'ang'a; Peter O Sumba; John Vulule; Robert Ploutz-Snyder; Arlene E Dent; Rosemary Rochford Journal: J Infect Dis Date: 2015-05-17 Impact factor: 5.226
Authors: Corey Casper; Elizabeth Krantz; Stacy Selke; Steven R Kuntz; Jie Wang; Meei-Li Huang; John S Pauk; Lawrence Corey; Anna Wald Journal: J Infect Dis Date: 2006-11-14 Impact factor: 5.226
Authors: H Kimura; M Morita; Y Yabuta; K Kuzushima; K Kato; S Kojima; T Matsuyama; T Morishima Journal: J Clin Microbiol Date: 1999-01 Impact factor: 5.948
Authors: Hlanai Gumbo; Bernard Chasekwa; James A Church; Robert Ntozini; Kuda Mutasa; Jean H Humphrey; Andrew J Prendergast Journal: PLoS One Date: 2014-12-18 Impact factor: 3.240
Authors: Frances M Saccoccio; Jennifer A Jenks; Hannah L Itell; Shuk Hang Li; Madison Berry; Justin Pollara; Corey Casper; Soren Gantt; Sallie R Permar Journal: J Infect Dis Date: 2019-07-31 Impact factor: 5.226
Authors: Cody S Nelson; Ilona Baraniak; Daniele Lilleri; Matthew B Reeves; Paul D Griffiths; Sallie R Permar Journal: J Infect Dis Date: 2020-03-05 Impact factor: 5.226
Authors: David H Mulama; Lorraine Z Mutsvunguma; Jennifer Totonchy; Peng Ye; Joslyn Foley; Gabriela M Escalante; Esther Rodriguez; Ramina Nabiee; Murali Muniraju; Felix Wussow; Anne K Barasa; Javier Gordon Ogembo Journal: Vaccine Date: 2019-06-11 Impact factor: 3.641
Authors: Eshan U Patel; Sara Gianella; Kevin Newell; Aaron A R Tobian; Allison R Kirkpatrick; Fredrick Nalugoda; Mary K Grabowski; Ronald H Gray; David Serwadda; Thomas C Quinn; Andrew D Redd; Steven J Reynolds Journal: AIDS Date: 2017-03-27 Impact factor: 4.177
Authors: Dirk P Dittmer; Kristen Tamburro; Huichao Chen; Anthony Lee; Marcia K Sanders; Tischan A Wade; Sonia Napravnik; Jennifer Webster-Cyriaque; Mahmoud Ghannoum; Caroline H Shiboski; Judith A Aberg Journal: AIDS Date: 2017-09-24 Impact factor: 4.177
Authors: Bryan T Mayer; Laura Matrajt; Corey Casper; Elizabeth M Krantz; Lawrence Corey; Anna Wald; Soren Gantt; Joshua T Schiffer Journal: J Infect Dis Date: 2016-09-20 Impact factor: 5.226